Page last updated: 2024-08-25

cromakalim and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole

cromakalim has been researched along with 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hatano, Y; Iranami, H; Iwahashi, S; Kakutani, T; Kinoshita, H; Mizumoto, K1

Other Studies

1 other study(ies) available for cromakalim and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole

ArticleYear
The role of endothelium-derived nitric oxide in relaxations to levcromakalim in the rat aorta.
    Japanese journal of pharmacology, 1999, Volume: 81, Issue:4

    Topics: Animals; Aorta, Thoracic; ATP-Binding Cassette Transporters; Benzoates; Cromakalim; Endothelium, Vascular; Enzyme Inhibitors; Glyburide; Guanylate Cyclase; Hydrazines; Imidazoles; KATP Channels; Male; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channels; Potassium Channels, Inwardly Rectifying; Rats; Rats, Inbred WKY; Vasodilator Agents

1999